Campylobacter jejuni is one of the leading infectious causes of food-borne illness around the world. Its ability to persistently colonize the intestinal tract of a broad range of hosts, including food-producing animals, is central to its epidemiology since most infections are due to the consumption of contaminated food products. Using a highly saturated transposon insertion library combined with next-generation sequencing and a mouse model of infection, we have carried out a comprehensive genome-wide analysis of the fitness determinants for growth in vitro and in vivo of a highly pathogenic strain of C. jejuni. A comparison of the C. jejuni requirements to colonize the mouse intestine with those necessary to grow in different culture media in vitro, combined with isotopologue profiling and metabolic flow analysis, allowed us to identify its metabolic requirements to establish infection, including the ability to acquire certain nutrients, metabolize specific substrates, or maintain intracellular ion homeostasis. This comprehensive analysis has identified metabolic pathways that could provide the basis for the development of novel strategies to prevent C. jejuni colonization of food-producing animals or to treat human infections.
There is accumulating evidence that in addition to canonical virulence factors such as toxins, adhesins, or invasins, bacterial pathogens utilize specific metabolic traits to colonize and proliferate within their hosts, a concept that is increasingly referred to as “nutritional virulence”. We have used transposon insertion mutagenesis combined with next-generation sequencing, a mouse model of infection, isotopologue profiling, and metabolic flow analysis to obtain a comprehensive view of the metabolic requirements for the intestinal colonization of C. jejuni, a leading cause of food-borne gastroenteritis in industrialized countries. This information could provide the basis to control C. jejuni colonization of food-producing animals or the human host.
Citation: Gao B, Vorwerk H, Huber C, Lara-Tejero M, Mohr J, Goodman AL, et al. (2017) Metabolic and fitness determinants for in vitro growth and intestinal colonization of the bacterial pathogen Campylobacter jejuni. PLoS Biol15(5): e2001390. https://doi.org/10.1371/journal.pbio.2001390
Academic Editor: Matthew Waldor, Brigham and Women's Hospital, United States of America
Received: October 20, 2016; Accepted: April 24, 2017; Published: May 19, 2017
Copyright: © 2017 Gao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The Ministry of Science and Culture of Lower Saxony (grant number Georg-Christoph-Lichtenberg Scholarship [to JM]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Deutsche Forschungsgemeinschaft (grant number HO 4553/2-1 [to DH]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institute for Allergy and Infectious Diseases (grant number AI R21AI112810 [to JEG]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: ABC, ATP-binding cassette; acetyl-CoA, acetyl coenzyme A; Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartic acid; Cdt, cytolethal distending toxin; CFU, colony-forming unit; CI, competitive index; CMP, cytidine monophosphate; CPS, capsule; Cys, cysteine; DMEM, Dulbecco’s Modified Eagle Medium; EMP, Emden-Meyerhof-Parnas; GA3P, glyceraldehyde-3-phosphate; GC/MS, gas chromatography/mass spectrometry; GDP, guanosine diphosphate; Gln, glutamine; Glu, glutamic acid; Gly, glycine; GTP, guanosine-5'-triphosphate; His, histidine; Ile, isoleucine; INSeq, insertion sequencing; Lac, lactate; Leu, leucine; LIV, leucine-isoleucine-valine; LOS, lipooligosaccharide; Lys, lysine; Met, methionine; NAD, nicotinamide adenine dinucleotide; OAA, oxaloacetate; ORF, open reading frame; PEP, phosphoenolpyruvic acid; Pfk, phosphofructokinase; PFOR, pyruvate ferredoxin/flavodoxin oxidoreductase; Phe, phenylalanine; PLP, pyridoxine-5′-phosphate; PPP, pentose phosphate pathway; Pro, proline; PRPP, phosphoribosyl pyrophosphate; Pyr, pyruvate; Rpe, ribulose-phosphate 3-epimerase; RpiB, ribose 5-phosphate isomerase B; SAM, S-adenosyl methionine; SD, standard deviation; Ser, serine; TCA, tricarboxylic acid; Thr, threonine; TPR, tetratricopeptide repeat; Trp, tryptophan; Tyr, tyrosine; Val, valine
Campylobacter jejuni subsp. jejuni (C. jejuni) is one of the most common causes of infectious food-borne illness in industrialized countries [1,2]. The high incidence of this pathogen is due to its ability to persistently colonize the intestinal tract of food-producing animals. Contaminated food products—in particular, poultry meat—become a source of C. jejuni infection when improperly handled or undercooked . While asymptomatic in most vertebrates, in humans, C. jejuni infection often leads to acute, although self-limiting, gastroenteritis . Rarely, infections with C. jejuni lead to a sequelae known as Guillain-Barre syndrome, which is characterized as a serious neurodegenerative disorder . A characteristic feature of C. jejuni that distinguishes it from other common enteropathogenic bacteria is the paucity of homologs of virulence factors that in other pathogens are engaged in specific interaction with the host [6,7]. In fact, C. jejuni has arguably more in common with commensal intestinal microbiota than with enteric pathogens. This is consistent with the observation that, other than in humans, the persistent presence of C. jejuni in the gut does not lead to pathology . Why and how C. jejuni infection in humans leads to disease is very poorly understood, but it is expected that its ability to colonize and replicate within the intestinal tract to reach significant numbers must be central to its pathogenesis. Several studies have identified genes that are important for C. jejuni intestinal colonization using different animal models of infection. Other than genes required for motility or the modification of surface structures (e.g., protein glycosylation), the vast majority of genes identified to date as required for colonization are involved in the acquisition and metabolism of essential nutrients [7,9–12]. Therefore, deciphering the metabolic requirements of C. jejuni is central to the understanding of its ability to colonize a host and potentially cause disease. In fact, the understanding of the metabolism of bacterial pathogens during infection is quickly emerging as an extremely important area of research. While the basic metabolism of model bacteria during their growth in vitro has been extensively studied, knowledge of the metabolic requirements of bacterial pathogens during infection has lagged behind . Indeed, it is becoming increasingly clear that the functional purpose of some virulence factors that specifically target host processes is to increase the availability of crucial nutrients or to facilitate their acquisition for bacterial growth. Therefore, the concept of “nutritional virulence factors” has been proposed to describe such pathogenic determinants [14–17].
Although most of the C. jejuni colonization determinants known to date have been discovered by candidate-mutant experimental approaches, there have been some attempts to comprehensively identify such determinants using genome-wide approaches [18–20]. However, because of technical limitations in the approaches or animal models used, those studies have not been comprehensive. The availability of high-throughput nucleotide sequencing technologies coupled to transposon mutagenesis has provided a powerful tool to interrogate highly saturated mutant libraries of insertion mutants for specific phenotypes [21–23]. This approach allows not only the comprehensive identification of virulence or colonization determinants but also the simultaneous measurement of the relative fitness cost resulting from the inactivation of potentially every nonessential gene under various environmental conditions. When applied to the understanding of metabolic requirements, such comparative analysis can provide a much more encompassing view of the relative importance of specific metabolic pathways under the conditions examined. An essential prerequisite for the application of high-throughput approaches to interrogate genomic libraries is the absence of bottlenecks that could limit the depth of coverage of the mutagenesis screen. Since in most animal models of infection C. jejuni cannot be recovered in large numbers , this has been a major limitation in previous attempts to broadly interrogate mutant libraries for their ability to colonize the intestine [19,25]. Recently, a mouse model of infection has been described that allows the replication of C. jejuni to large numbers , thereby overcoming previous limitations for the application of high-throughput genome-wide analyses. We report here the use of this animal model in combination with transposon mutagenesis and next-generation sequencing to comprehensively interrogate a highly saturated transposon insertion library of C. jejuni 81–176 for its ability to colonize the intestine. To provide a more robust framework for the interpretation of these results, we have also examined the mutant library after growth under different in vitro conditions. The combination of this extensive genetic approach with isotopologue profiling, metabolic flow examination, and the analysis of specific mutant strains amounted to the most complete analyses of the metabolic determinants necessary for a bacterial pathogen to colonize a mammalian host to date. Importantly, this analysis has identified key metabolic pathways that could be targeted for the development of novel strategies to prevent C. jejuni infection.
Results and discussion
Genome wide analyses of C. jejuni fitness determinants in rich and defined minimal media
We recently reported the construction of a highly saturated and randomly dispersed transposon mutant library composed of approximately 50,000 individual insertions with an average density of 31 insertions/kb across the C. jejuni 81–176 genome . Analysis of the library indicated that 90% of the 1,758 predicted open reading frames in the genome and its plasmids pTet and pVir harbored transposon insertions, whereas the remaining 10% of the genes were presumably essential under the conditions used to generate the library . We used this transposon mutant library to interrogate the fitness of the different C. jejuni mutants after growth in solid rich (blood agar) or defined liquid medium supplemented with asparagine (Asn), glutamine (Gln), or serine (Ser) as the main carbon sources (Fig 1).
(A) Diagram of the INSeq strategy used in these studies. (B) Histogram depicting the number of genes (y axis) that exhibited the indicated log2 (fold change [output/input]) change (x axis) in the numbers of transposon insertions recovered after growth on solid rich medium relative to the number of transposon insertions in the original inoculum. Areas colored with green represent genes whose number of transposon insertions showed a significant decrease after growth on solid rich medium. (C) Venn diagram showing the relationship between genes required for growth under different culture conditions identified in these studies. (D) Venn diagram depicting the relationship between genes whose inactivation led to increased growth in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with different amino acids. Twenty-two out of 34 genes whose mutation led to increased growth encode proteins associated with the flagellar motility system (see S2 Table for details). Asn, asparagine; CFU, colony-forming unit; Gln, glutamine; Ser, serine.
Comparison of the relative number of each transposon mutant remaining after 48 hours of growth under the different conditions with the number in the original inoculum identified 58 genes whose inactivation resulted in a growth defect under all conditions tested (Fig 1C, S1 and S2 Tables). Most of these genes are involved in basic metabolic processes such as nutrient transport and utilization, respiration, response to oxidative stress, cell envelope biogenesis, DNA replication and repair, translation, and protein turnover. This group of mutants also includes insertions in 13 genes whose functions are unknown. Insertions in 46 genes resulted in mutants with growth defects in defined liquid but not in solid rich media (Fig 1C and S2 Table). Among those, we identified mutations in genes involved in proline (proABC), biotin (bioAFD), and purine and pyrimidine (carB, pyrBF, and purEFHLMNQS) biosynthesis. These observations validated our experimental approach since the defined medium used in the screen lacked these substrates. The analysis of the results described below combined with isotopologue profiling and metabolic flow analysis provides a comprehensive view of the metabolic requirements for C. jejuni to grow in rich and defined media.
1. C. jejuni has restricted catabolic capacity but broad biosynthetic ability: Unexpected prominence for Serine utilization.
It is well established that C. jejuni has no glycolytic capacity and can utilize only a limited number of amino acids (aspartic acid [Asp], Asn, glutamic acid [Glu], Gln, proline [Pro], and Ser) as carbon and energy sources [28–31]. Our screen revealed that sdaC mutants, which are unable to transport Ser and show a reduced serine dehydratase activity , have a severe growth disadvantage on nutrient-rich blood agar plates. In contrast, inactivation of the genes putP (CJJ81176_1495), paq (CJJ81176_0492–0494), or peb (CJJ81176_0926–0929), which are required for the uptake of Pro, Gln, and Asp and Glu, respectively , did not hinder the in vitro growth of C. jejuni 81–176 in rich medium (S1 Table). These results revealed an unexpected prominence for Ser utilization in C. jejuni metabolism even in the presence of other nutrients. To investigate the role of Ser in fueling the intermediary metabolism and anabolism of C. jejuni 81–176, we used 13C-isotopologue profiling (see “Material and methods”). After C. jejuni cultivation in defined Dulbecco’s Modified Eagle Medium (DMEM) containing [3-13C1]Ser, we detected significant 13C-incorporation in 10 of 15 detectable protein-derived amino acids, with no or insignificant 13C-labeling of arginine (Arg), isoleucine (Ile), leucine (Leu), phenylalanine (Phe), and tyrosine (Tyr) (Fig 2A). These results suggest that these amino acids are preferentially imported from the culture medium. The deamination of [3-13C1]Ser catalyzed by the serine dehydratase SdaA generated [3-13C1]pyruvate and the robust 13C-labeling of Glu, Pro, and Asp (Fig 2B), which are derived from α-ketoglutarate (Glu and Pro) and oxaloacetate (OAA). These findings showed that a significant amount of catabolized Ser is converted to pyruvate (Pyr) and subsequently to acetyl coenzyme A (acetyl-CoA), thus feeding into the tricarboxylic acid (TCA) cycle. Although no gene encoding a putative alanine (Ala) aminotransferase that could convert Pyr to Ala is apparent in the genome of C. jejuni, single-labeled [3-13C1]Ala showed the second-highest 13C-excess after Ser (Fig 2A). The important role of Pyr in the anabolism of C. jejuni is further illustrated by the multilabeled lysine (Lys), generated through the condensation of [3-13C1]Pyr with 13C-labeled Asp, and the (M+2)-labeling of valine (Val), generated from two [3-13C1]Pyr molecules. In contrast to Val, the 2 other branched-chain amino acids Leu and Ile did not show significant 13C-inocorporation. This result correlates with a previous study demonstrating that Val is taken up by the leucine-isoleucine-valine (LIV) transport system to a lesser extent than Leu and Ile . Therefore, an increased Val biosynthesis appears to be required to fulfill the C. jejuni needs for this amino acid. We detected robust 13C-labeling of histidine (His), which is synthesized from phosphoribosyl pyrophosphate (PRPP). This sugar is generated from the Emden-Meyerhof-Parnas (EMP) pathway intermediates glyceraldehyde-3-phosphate (GA3P) and fructose-6-phosphate through the interconversion reactions of the reductive pentose phosphate pathway (PPP) branch, which demonstrates that C. jejuni 81–176 harbors an active gluconeogenesis and nonoxidative PPP (see below) (Fig 2B).
The intermediary metabolism of C. jejuni 81–176 was investigated through isotopologue profiling with 13C-labelled Ser. (A) Overall 13C-excess and relative fractions of 13C-labeled isotopologues in protein-derived amino acids gained by acidic hydrolysis of C. jejuni 81–176 cells after cultivation in Dulbecco’s Modified Eagle Medium (DMEM) with [3-13C1]Ser as determined by gas-chromatography/mass-spectrometry (GC/MS) analysis. The colored boxes indicate the relative contributions (%) of isotopologues with 1, 2, 3, 4, 5, and 6 13C-atoms indicated as M+1, M+2, M+3, M+4, M+5, and M+6, respectively. Values are the means ± standard deviation (SD) of 6 measurements (see S11 Table). (B) Overview of the anabolism in C. jejuni 81–176 fueled by the catabolism of [3-13C1]Ser. The dots illustrate the 13C-carbon flux from [3-13C1]Ser within the indicated molecules. Because of stereoisometry, the positioning of the 13C-atoms within succinate and fumarate is indistinguishable; thus, the resulting possibilities of the 13C-positions are indicated in red and orange as a 50% labeling probability for each. Green arrows display the biosynthetic pathways confirmed through isotopologue profiling. Acetyl-CoA, acetyl coenzyme A; Ala, alanine; Asp, asparagine; Glu, glutamic acid; Gly, glycine; His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Phe, phenylalanine; PEP, phosphoenolpyruvic acid; PPP, pentose phosphate pathway; Pro, proline; Ser, serine; TCA, tricarboxylic acid; Thr, threonine; Tyr, tyrosine; Val, valine.
We also examined the 13C-incorporation into polar metabolites after incubation of C. jejuni with [3-13C1]Ser and found a similar 13C-excess and distribution of isotopologue fractions in unbound or protein-derived Ala, Asp, glycine (Gly), methionine (Met), threonine (Thr), and Val (S1 Fig). Uracil was among the substrates with the highest 13C-excess, reflecting the importance of de novo pyrimidine biosynthesis when C. jejuni is cultivated in defined liquid medium. Accordingly, insertion mutants with inactivated purine and pyrimidine biosynthesis genes, such as purA/C, pyrD/E, and carA, exhibited strong growth defects after 48 hours of cultivation (S2 Table). The fatty acids C12-lauric and C16-palmitic acid showed the highest 13C-excess in our isotopologue profiling analysis, indicating that fatty acid biosynthesis is very active in C. jejuni. This observation is also consistent with the pronounced carbon flow from [3-13C1]Ser to acetyl-CoA via Pyr and the observed serial condensations of [2-13C1]acetyl-CoA molecules during the fatty acid elongation (Fig 2B and S1 Fig). Moreover, our insertion sequencing (INSeq) analysis indicated that the fatty acid biosynthesis genes fabDFGHZ seem to be essential for C. jejuni. Taken together, our analysis illustrates the highly versatile anabolic capacity of C. jejuni as exemplified by its competence in the de novo synthesis of most essential compounds, fueling its anabolism by the catabolism of a very narrow spectrum of carbon sources.
2. C. jejuni exhibits uptake capacity for noncatabolized amino acids that are directly incorporated into synthesized proteins.
Our in vitro INSeq analysis identified numerous transposon insertions in genes encoding biosynthetic pathways for the amino acids Arg, Asp, cysteine (Cys), Glu, Gln, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, tryptophan (Trp), and Val, which resulted in no measurable fitness cost (S1 Table, S2A Fig). These results indicate that through as of yet unidentified transporters, C. jejuni must be able to take up amino acids like Arg, Cys, His, Lys, Phe, or Thr, which cannot be utilized as an energy source but can be directly used for protein synthesis. To confirm such an extended amino acid uptake capacity, we constructed specific C. jejuni mutants defective for the synthesis of branched-chain amino acids (ilvD), Lys (lysA), Arg (argD), or Thr (thrB) and tested their growth in vitro. We found no substantial defects in the growth of these mutant strains in defined amino acid-rich medium (S2B Fig). Moreover, gas-chromatography/mass-spectrometry (GC/MS) analysis showed that after 24 hours of cultivation of C. jejuni 81–176 in defined amino acid-rich medium, Asp, Cys, Glu, Pro, Ser, Met, and Thr were significantly depleted from the culture medium (S3 Fig). The ability to take up noncatabolizable amino acids like Cys, Met, and Thr most likely provides a fitness advantage to C. jejuni by reducing the energy cost associated with the de novo synthesis of these amino acids .
3. Cofactors and vitamins in C. jejuni metabolism.
Besides its capacity to synthesize amino acids, genome sequence analysis indicates that C. jejuni 81–176 has the ability to synthesize several enzyme cofactors . Transposon insertions within genes involved in biosynthesis of nicotinamide adenine dinucleotide (NAD; nadDE), heme (hemABCDENHL), flavin/riboflavin (ribABEH), folate (folCDEP), thiamine (thiDEFGHS), or pyridoxine-5′-phosphate (PLP; pdxAJ, dxs) were absent or present at very low numbers in our library (S1 Table). Consequently, these genes are either essential or at least crucial for the growth of C. jejuni 81–176 under the conditions of our screen. Although panthothenate is required for coenzyme A synthesis, our analysis identified a large number of insertions within the pantothenate biosynthesis genes panBCD. Mutations in these genes did not show growth defect in vitro, indicating that C. jejuni 81–176 must be able to take up pantothenate from the growth medium. This result is in agreement with the recent observation that culture medium supplemented with pantothenate enhances the growth of C. jejuni .
Genome-wide analysis of C. jejuni metabolic determinants necessary for intestinal colonization in a mouse model of infection
It was recently reported that mice, rendered dysbiotic by antibiotic treatment, could be stably colonized by C. jejuni . We found that, predictably, antibiotic treatment drastically reduced though did not eliminate the bacterial load in the intestinal tract (S4 Fig). More importantly, we found that, consistent with previous reports , C. jejuni strain 81–176 can robustly colonize the intestinal tract of dysbiotic mice for up to 3 weeks after oral infection (Fig 3A). Large numbers of C. jejuni colony-forming units (CFUs) were recovered from the large intestine and cecum of infected animals as early as 4 days after infection and up to 21 days post infection, although colonization of systemic tissues was inefficient. Consequently, this infection model is suitable to screen a library with a large number of transposon insertion mutants for their ability to colonize the intestine as a strategy to identify metabolic determinants necessary for C. jejuni growth in this compartment. After oral inoculation of dysbiotic C57BL/6 mice with the C. jejuni 81–176 transposon insertion mutant library, the infected animals were killed 4, 7, or 21 days after infection, and C. jejuni CFUs were recovered from the cecum for INSeq analysis. About 1010 C. jejuni CFUs were recovered from the cecum of infected mice 4 days after infection, and between 108 and 109 CFUs were recovered 21 days after infection (Fig 3B). INSeq analysis of the inoculum revealed transposon insertions in 1,323 out of 1,758 predicted genes of C. jejuni 81–176. Since only insertions within the first 80% of the coding sequence were considered in the analysis, it is likely that all these insertions resulted in inactivation of the targeted genes. Analysis of the mutants recovered 21 days post infection revealed a marked increase in insertions within the pVir and pTet plasmids, with a marked reduction in the representation of the mutant pool (S5 Fig). The reasons for the “blooming” of these mutants late in infection are unclear, although our library already contained a preponderance of insertions within the resident plasmids, presumably because differences in DNA superhelicity may favor insertions into plasmid genes. Nevertheless, the blooming of plasmid insertion mutants observed at day 21 precluded the use of this time point to analyze C. jejuni colonization determinants. Examination of the mutant pool isolated 4 days after infection revealed the presence of an average of 935 mutants per animal (approximately 70% of the inoculum pool), and no indication of blooming since the relative number of insertions within plasmid or chromosomal genes recovered from the intestine was similar to their ratio in the inoculum (S5 Fig and S3 Table). Therefore, we chose this time point to identify genes involved in the initiation of C. jejuni colonization of the intestinal tract. The distribution of log2 values for the number of insertions in most genes showed an overall reduction in comparison with the inoculum (Fig 3C). We observed a similar distribution even when the data were normalized by an alternative approach (S6 Fig and S4 Table) (see “Materials and methods”). Although the reasons for this downshift in the population are not known and likely to be multifactorial, it is not unprecedented since it has been observed in previous similar studies . Consequently, the fitness defect of a given mutant could not be confidently derived by a given cutoff in the log2 ratio of the difference between the number of insertions recovered from the intestine versus the number in the original inoculum. Instead, we identified genes with fitness defects by applying statistical analysis to determine the likelihood that the differences in log2 ratios for any specific gene could have happened by chance (see “Materials and methods”). This analysis identified 143 genes that showed a significantly decreased number of insertions within the mutant pool recovered from the intestine relative to the inoculum (Fig 3C and 3D and Table 1). We found that insertions located immediately downstream of 126 out of the 143 genes identified did not result in attenuating phenotypes indicating that the transposon insertions do not result in polar effects on downstream genes (S5 Table). Mutations in 101 of these genes did not result in a fitness reduction when grown in rich medium (Table 1), suggesting that they may be specifically required for initiation of intestinal colonization. Mutations in the remaining 42 genes resulted in different degrees of fitness loss when C. jejuni was grown in vitro (Table 1).
Mice rendered dysbiotic by antibiotic treatment were orally infected with wild-type C. jejuni 81–176 (A) or a library of transposon-insertion mutants (B), and the number of colony-forming units (CFUs) in the ceca of infected animals was determined as indicated in “Materials and methods.” (C) Histogram depicting the number of genes (y axis) that exhibited the indicated log2 (fold change [output/input]) change (x axis) in the numbers of transposon insertions recovered from infected mice relative to the number of transposon insertions in the original inoculum. Areas colored with red represent genes whose number of transposon insertions showed a significant decrease after mouse infection. The calculation of log2 (fold change [output/input]) is based on the read numbers of insertional mutants of each gene presented in S3 Table. (D) Functional categories of the C. jejuni 81–176 genes whose inactivation led to mouse intestinal colonization defects as measured by INseq analysis. The genes belonging to each functional category can be found in Table 1. p.i., post infection.
Our INSeq screen identified attenuating transposon mutations in most of the genes that previous studies have shown to be required for intestinal colonization of C. jejuni 81–176 [19,33,38–42], which demonstrates the comprehensive nature of our approach. Thus, C. jejuni 81–176 mutants harboring transposon insertions within genes involved in motility, lipooligosaccharide and capsule biosynthesis, or N- and O-protein glycosylation, as well as metabolic traits, were readily detected among the pool of mutants showing reduced colonization (Table 1 and S6 Table). Notably, however, several mutations in genes encoding cytolethal distending toxin components (CdtA, CdtB, and CdtC) and other previously described putative virulence factors involved in cell adhesion and invasion such as CiaB/C/I, CadF, FlpA, JlpA, PldA, or HtrA resulted in either no fitness cost or a level of attenuation significantly lower than many mutations affecting metabolic processes (see below) (S3 Table). These observations underscore the relative importance of metabolism in C. jejuni intestinal colonization. Our analysis also identified insertions in many genes that have not been previously linked to intestinal colonization. What follows is an analysis of these findings aided by the framework provided by the information obtained through studies of the requirements for C. jejuni growth under different in vitro culture conditions.
1. Chemotaxis and motility.
Chemotactic motility towards preferred nutrients, such as the amino acids Asp, Glu, and Ser, are essential for C. jejuni virulence and colonization [43,44]. Predictably, we identified several chemotaxis-associated genes that are required for mouse colonization (Table 1). Specifically, insertions in the genes encoding the chemotaxis-associated regulatory proteins CheA, CheV, and CheW and the accessory proteins CheR, CheX, and ChePep resulted in a significant decrease in the ability of C. jejuni to colonize the gut. Aspartate catabolism promotes C. jejuni infection [45,46], and the chemoreceptors Tlp1 and Tlp3 have been shown to interact with Asp [47,48]. Although tlp3 appears to be a pseudogene in C. jejuni 81–176 , insertions within tlp1 (CJJ81176_1498) resulted in a moderately significant attenuation (S6 Table). However, inactivation of other methyl-accepting Tlp proteins did not affect the ability of C. jejuni to colonize the murine intestine to the same extent (S7 Table). These results indicate that while chemotaxis is certainly required for colonization, there is likely to be significant redundancy in the function of the receptors that mediate the sensing of the different relevant chemoattractants.
Our analysis also revealed that insertions in any of 22 genes previously linked to motility resulted in a significant reduction in colonization (Table 1). These included the recently reported motility-associated genes pflB (CJJ81176_0413), flgV (CJJ81176_0100) , and CJJ81176_0481 . The gene CJJ81176_0481 is organized in an operon with the downstream genes CJJ81176_0480 and CJJ81176_0479, which we found are also required for full motility and intestinal colonization (S7A and S7B Fig). Interestingly, insertional inactivation of more than 20 motility genes conferred an advantage during growth in liquid media (S2 Table, S7C Fig). These results imply that flagellar motility does not confer an advantage for C. jejuni growth in homogenous liquid medium and suggest that, under certain conditions, the metabolic cost of producing flagella may lead to the down-regulation of its expression. It has been demonstrated that the expression of several motility genes (e.g., motA and flgRS) in C. jejuni is controlled by phase-variable mechanisms [51–53]. Since insertional mutations in these phase-variable genes conferred a growth advantage in vitro, shutting down flagellar expression at some point during infection may have a beneficial effect for colonization. For example, it is possible that once C. jejuni has reached its preferred colonization sites, the mucus-filled intestinal crypts [54–56], motility might at least temporarily no longer confer an advantage. Instead, the phase-variable loss of motility might allow C. jejuni to more effectively utilize energy and carbon sources, thereby enhancing its ability to proliferate and persist in the mucus layer.
2. Amino acid and peptide catabolism.
Our INSeq analysis revealed that inactivation of peb1A (CJJ81176_0928), which participates in the utilization of Asp, Glu, Asn, and Gln [29,57], and its downstream genes (CJJ81176_0926, CJJ81176_0927) led to a significant decrease in colonization (Fig 4A). A similarly severe loss of colonization was observed for insertion mutants in paqPQ (Fig 4A), which encode a transporter that participates in the uptake of Gln and, to a lesser extent, Glu, Cys, and Asp . In contrast to our previous study , mutants with defective Ser and Pro catabolism showed no colonization defect in this screen. This apparent discrepancy is likely due to the different animal models used in these studies and differences in the days after infection in which bacterial loads were examined (i.e., 4 days versus 5 weeks). Inactivation of the genes encoding the putative Ser/Thr (CJJ81176_1115) and Met (CJJ81176_0793–0795) transporters also resulted in a pronounced colonization defect, suggesting that these predicted transporters are functional in C. jejuni (Fig 4A). Indeed, as mentioned in our metabolic footprint analysis, we detected a significant reduction of Thr and Met after C. jejuni growth in casein hydrolysate medium, confirming that these amino acids can be taken up by C. jejuni (S3 Fig). Transposon insertions within the genes livFGMKJ, which encode a high-affinity branched-chain amino acid ATP-binding cassette (ABC) transporter, resulted in a drastic reduction in C. jejuni intestinal colonization (Fig 4A and S3 Table). Similarly, inactivation of livK and livJ resulted in a severe colonization defect in a chicken model of infection . As Leu, Ile, and Val are not catabolized by C. jejuni, these findings suggest that the acquisition of branched-chain amino acids must be crucial for protein synthesis during C. jejuni infection.
(A and B) Impact of the mutations in genes involved in the transport, metabolism (A), or biosynthesis (B) of amino acids and peptides that are important for C. jejuni colonization as determined by insertion sequencing (INSeq) analyses. The log2 (fold change [intestine/inoculum]) in the number of transposon insertions within the depicted C. jejuni genes are shown, and when depicted in red, the value indicates a statistically significant colonization defect. *: denotes genes showing a limited number of insertions within the library and no insertions within the pooled of mutants recovered from the intestine. The red arrows in panel (B) denote that the number of insertions within the gene involved in the indicated reaction was significantly reduced within the pooled of mutants recovered from the mouse intestine (relative to the inoculum). The log2 (fold change [intestine/inoculum]) depicted beside each gene is taken from S3 Table. Asp, asparagine; Cys, cysteine; Gln, glutamine; Glu, glutamic acid; Gly, glycine; Ile, isoleucine; Leu, leucine; Met, methionine; OAA, oxaloacetate; SAM, S-adenosyl methionine; Ser, serine; TCA, tricarboxylic acid; Thr, threonine; Val, valine.
The limited number of metabolizable amino acids would appear to be a limitation in the ability of nonglycolytic C. jejuni to acquire nutrients. However, our INSeq analysis revealed that the catabolism of peptides, presumably released from the diet or from host-derived proteins by the host digestive enzymes and/or the intestinal microbiota , may be important for C. jejuni colonization. Although transposon insertions in several genes encoding peptidases (CJJ81176_0166, CJJ81176_0488, CJJ81176_0746, CJJ81176_0826, CJJ81176_1249, and CJJ81176_1291) resulted in no or moderate intestinal colonization defects, presumably due to redundancy in their activities, inactivation of the cytoplasmic zinc metalloendopeptidase PepF (CJJ81176_1117), the putative family C26 endopeptidase CJJ81176_1416, or the carboxyl-terminal protease CtpA (CJJ81176_0539) resulted in a severe colonization defect (Fig 4A, S3 Table). These results are consistent with previous in vitro studies indicating that C. jejuni can utilize dipeptides and tripeptides as a source of amino acids such as Glu and Cys that can serve as an energy/carbon source or can be used in protein biosynthesis .
3. Amino acid biosynthesis.
Despite the fact that C. jejuni 81–176 is able to take up most amino acids under in vitro growth conditions, our INSeq analysis revealed that its ability to synthesize several amino acids de novo is central for intestinal colonization (S8 Fig and S3 Table). In particular, the de novo synthesis of the branched-chain amino acids Leu, Ile, and Val is essential to colonize mice since insertional mutations in ilvC (CJJ81176_0660) and ilvE (CJJ81176_0296) and invH (CJJ81176_0603) were recovered in significantly lower number from the mouse intestine (Fig 4B). The requirement for both the acquisition and the synthesis of branched-chain amino acids implies that there is a high demand for these amino acids to sustain normal protein synthesis since branched-chain amino acids cannot be used as carbon source. Consistent with this hypothesis, branched-chain amino acids constitute 24.5% of the predicted C. jejuni 81–176 proteome (S9 Fig).
Transposon insertions in the Ser biosynthesis genes serAB resulted in a significant colonization defect (Fig 4B). This observation is surprising because C. jejuni can efficiently take up and utilize Ser as growth substrate. Moreover, the serAB mutants showed no growth defects when cultivated on nutrient-rich blood agar plates (S1 Table). Although Ser is abundantly present in animal feces , a restricted Ser supply at the C. jejuni colonization site may be responsible for the colonization defect observed in the serAB mutants. Furthermore, we found that in Ser-rich (2 mM) defined medium with an additional growth substrate, the added Ser seems to be insufficient for de novo protein synthesis in a C. jejuni serA mutant (S10A Fig). Isotopologue profiling experiments revealed that the imported free Ser is efficiently used as a carbon and energy source (Fig 2), thus potentially limiting the availability of free Ser for protein synthesis. Accordingly, the growth defect of the C. jejuni serA mutant could be overcome by introducing an additional mutation in the serine dehydratase sdaA gene, which prevents the degradation of the imported Ser (S10A Fig), or by increasing the amounts of free Ser (S10B and S10C Fig). Together, our results suggest that during colonization the imported Ser is efficiently catabolized by C. jejuni to fuel the TCA cycle, thereby limiting its intracellular accumulation and subsequent incorporation into newly synthesized proteins. In contrast, peptide-bound Ser in the form of the dipeptide Leu-Ser promoted the in vitro growth of the C. jejuni serA mutant more efficiently than free Ser (S10D Fig). This observation further stresses the importance of peptide utilization for the proliferation of C. jejuni. Further in vivo studies will be required to clarify the potentially different intracellular fates of free and peptide-bound Ser in this pathogen.
C. jejuni 81–176 does not seem to depend on the de novo synthesis of Met during mouse colonization since no insertional mutants of genes involved in Met biosynthesis (metAXCE) showed a significant colonization defect (S11 Fig). However, the INSeq analysis revealed that a putative Met transporter encoded by metNIQ is required for intestinal colonization, suggesting an important role for Met in C. jejuni physiology in the gut (Fig 4A, Table 1). In addition to protein synthesis, Met is crucial for bacterial physiology as a precursor of S-adenosyl methionine (SAM), a major methyl donor required for the methylation of DNA, RNA, proteins, and lipids through the activity of SAM-dependent methyltransferases . We did not identify any gene encoding an obvious homolog of a SAM transporter in the C. jejuni 81–176 genome. However, the C. jejuni 81–176 genome harbors a metK homologue, which encodes a SAM synthetase that converts Met directly to SAM. We detected very few insertions within metK in our transposon library (7 reads per 106 total reads, all located at the same site), and none of the metK insertional mutants were recovered from the mouse intestine or after in vitro growth, which indicates a critical role for SAM in C. jejuni physiology (S1 and S3 Tables). Therefore, we hypothesize that Met transport is crucial for C. jejuni growth in vitro and in vivo as a precursor for SAM biosynthesis.
4. The TCA cycle and acetate switch.
The INSeq analyses revealed that the central metabolism enzymes GltA, SucCD, and FrdABC, which catalyze various TCA cycle reactions, are critical for C. jejuni growth in defined medium and crucial for mouse colonization (Fig 5 and Table 1). Strikingly, the gltA, sucCD, and frdAC mutants showed no comparable growth defects when cultivated on nutrient-rich blood agar plates (Table 1), suggesting that in the intestine, C. jejuni must reside in a nutritionally restricted environment. Similarly, in agreement with previous reports [46,45], inactivation of aspA or aspB, whose products fuel the TCA cycle by catalyzing the catabolism of Asp and Glu, did not hinder the growth of C. jejuni on blood agar plates but led to a severe reduction in intestinal colonization. These observations indicate that Asp and Glu are among the most important carbon sources for C. jejuni in the gastrointestinal tract (Fig 4). Isotopologue profiling experiments with [5-13C1]Glu confirmed the central role of glutamate in the anabolism of C. jejuni, fueling gluconeogenesis and the nonoxidative PPP as demonstrated by the detection of 13C-labeled Ser, Gly, and His (S12 and S13 Figs). The anabolism and energy production through Glu catabolism require the AspB-catalyzed deamination of Glu to 2-oxoglutarate, which is then converted to malate and oxaloacetate (Fig 5). Subsequently, the decarboxylation of malate catalyzed by Mez (CJJ81176_1304) or the conversion of oxaloacetate through the concerted activities of PckA (CJJ81176_0939) and Pyk (CJJ81176_0415) generates Pyr, the precursor for many anabolic reactions (Fig 5). The INSeq analysis revealed that Mdh, Mez, and Pyk play a crucial role during C. jejuni colonization of the mouse intestine, although they are less important for the in vitro growth in rich media (Fig 5 and Table 1). Thus, our findings place Pyr at the center of the carbon flow of C. jejuni during gut colonization.
The log2 (fold change [intestine/inoculum]) in the number of transposon insertions within C. jejuni genes encoding enzymes in the tricarboxylic acid (TCA) cycle, gluconeogenesis, and the acetate switch pathways are shown and are derived from the raw data in S3 Table. Values below −6.2 indicate mutations that led to a statistically significant colonization defect. *: denotes genes showing a limited number of insertions within the library and no insertions within the pooled of mutants recovered from the intestine. The red arrows denote that the number of insertions within the gene involved in the indicated reaction was significantly reduced within the pool of mutants recovered from the mouse intestine (relative to the inoculum). Green arrows indicate that the enzyme that catalyzes the corresponding reaction does not have an insertional mutant in our mutant library. Enzymes not encoded in the C. jejuni genome are indicated with an “X.” The inset depicts the overall 13C-excess and relative fractions of 13C-labeled isotopologues in free and bound glucose or galactose (as indicated) derived from C. jejuni 81–176 cell surface carbohydrates after cultivation in Dulbecco’s Modified Eagle Medium (DMEM) with [3-13C1]Ser. The colored boxes indicate the relative contributions (%] of isotopologues with 1, 2, and 3 13C-atoms indicated as M+1, M+2, and M+3, respectively. Numbers are the means ± standard deviation (SD) of 6 measurements (see S11 Table). Acetyl-CoA, acetyl coenzyme A; LOS, lipooligosaccharide; OAA, oxaloacetate; PEP, phosphoenolpyruvic acid; PPP, pentose phosphate pathway.
As an energy source, Pyr can be degraded by C. jejuni to CO2 through the TCA cycle or fermented to acetate (Fig 5). In both cases, the first catabolic intermediate is acetyl-CoA, which is generated through the pyruvate ferredoxin/flavodoxin oxidoreductase (PFOR) (CJJ81176_1469) . We recovered very few transposon insertions within PFOR in our original C. jejuni mutant library and none from infected mice (S1 and S3 Tables), indicating that the production of acetyl-CoA is vital for both in vitro growth and intestinal colonization. Acetyl-CoA can be converted to acetyl phosphate and subsequently to acetate by the concerted activities of the phosphate acetyltransferase Pta (CJJ81176_0711) and the acetate kinase AckA (CJJ81176_0712) . This substrate-level phosphorylation reaction allows C. jejuni to generate ATP to energize its anabolism in an environment that lacks sufficient amounts of oxygen or alternative electron acceptors for oxidative phosphorylation (Fig 5). Alternatively, Pta, AckA, and also the acetyl-CoA synthetase Acs (CJJ81176_1522) can catalyze the reverse reaction generating acetyl-CoA from acetate. This so-called “acetate switch” occurs in vitro during the stationary growth phase of C. jejuni . While mutants with an inactivated acs gene showed no colonization defect, transposon insertions in both pta and ackA were recovered in significantly reduced numbers from infected animals, indicating that this pathway is essential for mouse colonization (Table 1). This observation was confirmed in infection experiments in which drastically lower numbers of a C. jejuni ΔackA mutant were recovered from mice when competed against the wild-type strain (S14 Fig). As the C. jejuni pta and ackA transposon insertion mutants exhibited no in vitro growth defect on blood agar plates, our infection experiments suggest that ATP generation through substrate-level phosphorylation during the conversion of acetyl-CoA to acetate and an operational “acetate switch” are required for mouse colonization. C. jejuni can utilize acetate in vitro , and our INSeq analysis suggests that C. jejuni might take advantage of the acetate produced by the intestinal microbiota to fuel its TCA cycle and balance its anabolic metabolism through the concerted activities of Pta and AckA. Additionally, the intermediate acetyl phosphate is involved in gene regulation as a potential phosphorylation donor , which suggests that the regulatory effect of acetyl phosphate might also contribute to intestinal colonization.
5. Gluconeogenesis and the nonoxidative pentose phosphate pathway.
C. jejuni does not catabolize glucose, as it lacks the genes encoding the enzymes for the oxidative pentose phosphate and Entner-Doudoroff pathways as well as the gene for the glycolytic enzyme phosphofructokinase (Pfk) of the Emden-Meyerhof-Parnas (EMP) pathway . Nevertheless, our INSeq analyses showed that C. jejuni depends on the gluconeogenic activity of the EMP pathway for in vitro growth in rich and defined media as well as for the colonization of the mouse intestine. Accordingly, insertions in genes within the EMP pathway were either missing (fbp) or present in very low numbers (fbaA, gapA, pgk, pgm, and eno) in our mutant library, and none of these mutants were recovered from the mouse intestine (Fig 5 and S1 and S3 Tables). These results suggest that gluconeogenesis is the only mechanism by which C. jejuni can obtain glucose and other EMP-pathway intermediates that are precursors for the nonoxidative PPP. Consequently, C. jejuni utilizes gluconeogenesis for the synthesis of carbohydrates, which are incorporated into essential virulence factors such as its lipooligosaccharide (LOS) and capsule (CPS) as well as the N-linked heptasaccharides of glycoproteins that play essential roles for C. jejuni proliferation in mice. Isotopologue profiling experiments with [3-13C1]Ser or [5-13C1]Glu demonstrated the existence of a reverse EMP pathway in C. jejuni since we detected 13C-labeled glucose and galactose derived from the LOS- and CPS-containing surface glycan (Fig 5, S13 Fig). However, C. jejuni cannot generate glucose from [3-13C1]Ser through its direct conversion to Pyr and phosphoenolpyruvic acid (PEP) because of the lack of a PEP synthetase. Consequently, Pyr, derived from Ser, must enter the EMP pathway either through the PFOR-catalyzed decarboxylation as acetyl-CoA in the TCA cycle or through its direct carboxylation by the pyruvate carboxylase Pyc (PycB: CJJ81176_0940; PycA: CJJ81176_0956) to generate the TCA cycle intermediate OAA. C. jejuni encodes a PEP carboxykinase (PckA; CJJ81176_0939) that converts OAA into PEP, which fuels the reverse EMP pathway for the synthesis of cell surface carbohydrates, or serves as substrate for other anaplerotic reactions. Indeed, our in vitro and in vivo INSeq analyses indicate that pckA is an essential gene (Fig 5), which is consistent with previous observations . Moreover, our analysis revealed that the nonoxidative PPP enzymes ribose 5-phosphate isomerase B (RpiB) and ribulose-phosphate 3-epimerase (Rpe) are essential for the growth of C. jejuni in vitro and in vivo (S1 and S3 Tables, S15 Fig). The nonoxidative PPP facilitates the generation of aromatic amino acids and His, as well as purines and pyrimidines from EMP pathway intermediates. Insertion mutants within genes encoding enzymes of the purine and pyrimidine biosynthesis pathways were recovered in significantly reduced numbers from infected mice (Table 1, S3 Table). Inactivation of the purS, purQ, purL, carB, pyrB, or pyrF genes resulted in mutants with normal growth phenotypes in rich medium but significant colonization defects in mice (S1 and S3 Tables, S16 Fig), suggesting the presence of yet unidentified purine and pyrimidine transporters in C. jejuni and indicating that both nucleotides may be in short supply within the mouse intestinal tract. Together, our study demonstrates a central role for the gluconeogenesis and PPP pathways of C. jejuni in intestinal colonization.
6. CO2 utilization.
Our findings indicate that the link between the TCA cycle and the EMP pathway via the PEP-Pyr-OAA-malate node is critical for C. jejuni to adjust the carbon fluxes to its energetic and anabolic needs both for its growth in vitro and during intestinal colonization (Fig 5). Maintenance of the intracellular OAA pools is indeed essential for growth and can be achieved by fueling the TCA cycle through the catabolism of Asp, Glu, Pro, and Ser or by carboxylating Pyr through the activity of Pyc . The CO2 required for this reaction might be generated intracellularly, for example, through the decarboxylation of TCA cycle intermediates or during the biosynthesis of fatty acids (S17 Fig). In the intestine, however, C. jejuni may be able to acquire the CO2 generated as a catabolic end product from the fermentation activity of the intestinal microbiota or directly from the host . Various CO2-incorporating metabolic reactions require hydrogen carbonate (HCO3-) instead of gaseous CO2 (Fig 6A), and the hydration of CO2 to HCO3- depends in C. jejuni on the carbonic anhydrase CanB (CJJ81176_0262) (Fig 6B), which promotes its growth in vitro . Besides facilitating the carboxylation reactions, the generated HCO3- might be required for maintaining the intracellular pH homeostasis . In addition, our INSeq analysis suggests that metabolic reactions with hydrogen carbonate are crucial for C. jejuni growth in the mouse intestine as revealed by the attenuated phenotypes observed for insertions within the genes carAB (CJJ81176_1486 / CJJ81176_0305), which encode a carbamoyl phosphate synthase (Fig 6A, S3 Table). Cultivation of C. jejuni in medium with 13C-labeled hydrogen carbonate (HCO3-) demonstrated CO2 incorporation into protein-derived amino acids (Fig 6C). In particular, the 13C-labeling of Asp and the amino acids Lys and Thr, which derive from Asp, illustrates the Pyc-mediated carboxylation of Pyr to OAA, which is subsequently converted to Asp by amination. Inactivation of pycA resulted in a slight but significant reduction in 13C-labeling of the detected amino acids, mainly Asp (Fig 6D), demonstrating the redundancy in HCO3- incorporation by the carboxylating enzymes in C. jejuni (Fig 6A). The inability of the C. jejuni pycA mutant to metabolize HCO3- led to a reduction in its in vitro growth, especially when cultivated with Ser and lactate as sole energy source (Fig 6E), similar to what has been previously described for the canB mutant . However, the pyc mutants showed no significant colonization defect in mice (Fig 6A), indicating that the amount of OAA, generated through the catabolism of growth substrates that fuel the TCA cycle, is sufficient for its gluconeogenic requirements. In contrast, the canB (CJJ81176_0262) mutant was highly attenuated in our infection experiments (Fig 6B and Table 1), demonstrating that the ability of the capnophilic C. jejuni to utilize CO2 for its carboxylation reactions is essential for its ability to colonize the intestine.
Illustrated are metabolic reactions in C. jejuni that utilize bicarbonate (H2CO3-) (A) and the carbonic anhydrase CanB-catalyzed reaction that generates bicarbonate from CO2 (B). Numbers indicate the log2 (fold change [intestine/inoculum]) in the number of insertions in the indicated genes and are derived from the raw data in S3 Table. Values below −6.2 indicate mutations that led to a statistically significant colonization defect. Green arrows indicate mutations that led to a statistically significant colonization defect. (C) Incorporation of CO2 into amino acids after C. jejuni 81–176 cultivation in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with H13CO3-. Shown are the overall 13C-excess (%) (upper panel) and relative fractions of 13C-labeled isotopologues (lower panel) in protein-derived amino acids of C. jejuni 81–176 cultivated in DMEM supplemented with 44 mM 13C-labeled hydrogen carbonate. The colored boxes indicate the relative contributions (%) of isotopologues with 1, 2, 3, 4, 5, and 6 13C-atoms (M+1, M+2, M+3, M+4, M+5, and M+6). Numbers are the means ± standard deviation (SD) of 6 measurements (see S11 Table). (D) Heat map for the overall 13C-excess of labeled amino acids in C. jejuni 81–176 wild-type and the respective pycA::Cm mutant strain after growth with [13C]bicarbonate and 20 mM lactate (upper panel) or 20 mM Ser (lower panel) as carbon and energy sources. The values of the color map depict the mean of 2 biological experiments measured in triplicate (see S11 Table). (E) Growth analysis of the C. jejuni 81–176 pycA mutant (grey column) compared to the wild type (black column) when cultivated in DMEM supplemented with 20 mM of different carbon and energy sources. Values represent the mean values ± SD of 3 independent experiments (see S12 Table). Ala, alanine; Asp, asparagine; Glu, glutamic acid; Gly, glycine; Ile, isoleucine; Lac, lactate; Leu, leucine; Lys, lysine; Phe, phenylalanine; Pro, proline; Ser, serine; Thr, threonine; Tyr, tyrosine; Val, valine; w/o, without; WT, wild type.
7. Transient metal cofactors.
Maintaining the homeostasis of ions is crucial for the viability of bacteria. The micronutrients copper (Cu), iron (Fe), manganese (Mn), magnesium (Mg), molybdenum (Mo), nickel (Ni), tungsten (W), and zinc (Zn) are required as cofactors for the activities of various enzymes. Although traces of these transient metals are essential for bacterial growth, elevated ion concentrations have toxic effects [72,73]. Animal hosts use transient metals as part of their nutritional immunity to fight invading pathogens by either restricting the access to free ions like Fe, Mg, and Mn or generating an environment with elevated concentrations of other metals such as Cu, which is toxic for bacteria. Consequently, pathogens require sufficient ion import and efflux mechanisms to overcome these host defense mechanisms and to balance their ion homeostasis . Consistent with the importance of Mg2+ in C. jejuni physiology, we found very few insertions within the magnesium transporter gene corA (CJJ81176_0749) in our transposon mutant library. Furthermore, as previously shown in chickens , we recovered very few insertions within the znuABC operon, which encodes a zinc transporter, from the pool of mutants obtained from the mouse intestine (Table 1). In contrast, inactivation of the putative zinc transporter ZupT (CJJ81176_0290) did not hinder the intestinal colonization of C. jejuni (Fig 7A), suggesting a less prominent role for this transporter. C. jejuni utilizes molybdate as cofactors for respiratory enzymes like the nitrate reductase and sulfite oxidase . Insertions within the genes encoding the molybdenum cofactor biosynthesis gene mogA (CJJ81176_0748) and the molybdopterin biosynthesis genes MoaA (CJJ81176_0197), MoaE (CJJ81176_1510), and MoeA (CJJ81176_0873) were greatly reduced in the mouse intestine, indicating that molybdenum plays an important role during C. jejuni intestinal colonization (Fig 7A, S3 Table).
Overview of insertion sequencing (INSeq) data for putative transporters in C. jejuni 81–176 mediating the transport of transition metals (A) and facilitating the homeostasis of protons and sodium or the uptake of solutes by cotransport (B). (C) Comparison of the relative contribution of 2 predicted potassium transport systems (Ktr and Kdp) to C. jejuni mouse colonization. Blue and red bars indicate the normalized read number of each insertion site within the open reading frames (ORFs) in the input and output pool, respectively. (D) Role of the Ktr and Kdp potassium transport system in mouse colonization. Mice were inoculated with an equal number of wild-type C. jejuni and the indicated mutant or complemented mutant strains via oral gavage (n = 5 or 7). Competitive indices (CIs) were calculated as the ratio of the colony-forming units (CFUs) of the mutant over the CFUs of the wild-type strain recovered from the ceca of infected mice (see S14 Table). Significance was determined by the unpaired t test. ***: p = 0.001; ****: p < 0.0001. (E) Growth of C. jejuni ktr and kdp mutants in defined rich medium supplemented with various K+ concentrations, as indicated. All strains were inoculated to culture medium at an OD600 of 0.02, and the cell density of the cultures was measured at the indicated times over a 46-hour period. Pro, proline; Ser, serine.
Unexpectedly, transposon insertions within genes involved in iron uptake systems did not have a major impact on the colonization capacity of C. jejuni 81–176 (S3 Table). C. jejuni 81–176 encodes at least 5 transporter systems related to iron uptake, such as CeuBCDE (CJJ81176_1351–1354), FeoAB (CJJ81176_1395–1397), ChuABCD (CJJ81176_1601–1604), CfbpABC (CJJ81176_0209–0211), and Ftr1/P19 (CJJ81176_1649–1650), and these results suggest a potential redundancy in the mechanisms utilized by C. jejuni to acquire iron.
Elevated Cu concentrations are used as a host defense mechanism against pathogenic microorganisms by facilitating the generation of reactive oxygen and nitrogen species. The periplasmic copper oxidase CeuO (CJJ81176_1508) and the copper exporter CopA (CJJ81176_1176) mediate the copper tolerance of C. jejuni in vitro . Surprisingly, however, transposon insertions within ceuO or copA did not result in significant colonization defects (Fig 7A, S3 Table). Instead, we found that insertions within genes encoding a second predicted copper oxidase, CJJ81176_1230, significantly affected the ability of C. jejuni to colonize the mouse intestine. A similar colonization defect was observed in insertions within czcD, which encodes a putative cobalt-zinc-cadmium efflux system protein (CJJ81176_1178) (S3 Table). These observations suggest that C. jejuni may be able to neutralize the Cu-mediated host defense mechanism through the activity of these 2 proteins.
8. Sodium, proton, and potassium transporters.
Protons (H+) and sodium (Na+) ions participate in the regulation of the cellular pH in bacteria , whereas potassium ions (K+) have a central role in sustaining turgor pressure . C. jejuni encodes 2 putative homologs of transport proteins of the Na+/H+ antiporter family (S3 Table), which play a key role in pH and Na+ homeostasis . Inactivation of one of them, the putative NhaA homolog CJJ81176_1645, led to a severe intestinal colonization defect with no in vitro phenotype (Fig 7B and S3 Table). The significance of this observation, however, is uncertain since the actual substrate specificity of this putative transporter is unknown but suggests an important role in intracellular pH regulation in intestinal colonization.
Protons and sodium ions also participate in the transport of growth substrates through the activity of various symporters. In addition to the sodium and proton symporters PutP and SdaC (Fig 7B), which are utilized in the transport of Pro and Ser, C. jejuni encodes other putative sodium symporters such as CJJ81176_0052, CJJ81176_0629, CJJ81176_0941, and CJJ81176_0942. Interestingly, insertion mutants within CJJ81176_0942 were recovered in drastically reduced numbers from the mouse intestine, although they did not incur a fitness cost when grown in vitro (Table 1). The interpretation of this observation, however, awaits the identification of the actual substrate of this putative symporter.
To ensure the maintenance of the potassium-dependent turgor pressure, bacteria are often equipped with several K+ import systems, such as the low-affinity but constitutive Trk and Kup transporters, the Na+-dependent Ktr importer, or the high-affinity and inducible Kdp transport system [78,79]. C. jejuni 81–176 encodes homologues of the Kdp and Ktr systems (S8 Table). Insertions in the ktrAB and kdpABCD genes resulted in no significant fitness cost after growth in vitro (Fig 7C and S1 Table). Strikingly, however, the number of insertions within the ktrAB locus was drastically reduced in the pool of mutants recovered from mice (Fig 7C and S3 Table). In contrast, the kdpABCD mutants were not affected in their ability to colonize the mouse intestine. To further clarify the role of the K+ transport systems in C. jejuni 81–176, we constructed strains carrying mutations in the ktr or kdp transport systems and examined their ability to colonize the mouse intestine in coinfection experiments with the wild-type strain (Fig 7D). Similar to what we observed in the INSeq analysis, we found that the C. jejuni ΔktrA mutant was drastically impaired in its ability to colonize the mouse intestine and that the colonization defect was fully reversed upon reintroduction of a wild-type copy of ktrA. In contrast, we found that the ΔkdpA mutant was able to colonize the mouse intestine at levels equivalent to those of the wild type. We also tested the growth of ktr and kdp mutants in defined medium in the presence or absence of KCl (Fig 7E). In the absence of KCl supplementation, only the wild-type strain showed measurable growth, although at reduced levels. In the presence of KCl, the wild type and ΔkdpA mutant strains were able to grow at equivalent levels, while the growth of the ΔktrA and ΔktrB mutant strain was significantly impaired. Growth of the ΔktrA mutant strains was restored upon reintroduction of a wild-type copy of the ktrA gene. These results indicate that the KtrAB K+ transport system plays a central role in C. jejuni physiology and mouse colonization.
It has become increasingly clear that the ability to secure nutrients is a key determinant of bacterial pathogenesis [14,16,80]. Our in vivo INSeq analysis has provided evidence that during the infection process C. jejuni relies more on specific metabolic adaptations than on specific virulence factors targeting host processes. In contrast to other intestinal pathogens, like Salmonella or pathogenic Escherichia coli [81–83], C. jejuni utilizes a limited number of carbon and energy sources. However, since low C. jejuni infectious doses are sufficient to cause disease [84,85], such metabolic restrictions do not seem to impede the ability of C. jejuni to overcome the microbiota-mediated colonization resistance. In fact, it is possible that C. jejuni may rely on the microbiota to provide essential nutrients to fuel its metabolism. We find that C. jejuni can utilize potential catabolic end products of the intestinal microbiota such as acetate or CO2-derived hydrogen carbonate and especially free amino acids and di-/ or oligopeptides, which are released from dietary or endogenous proteins. Although free amino acids and dipeptides are prominent in the mucus layer of the small intestine, our study suggests that the concentration of some amino acids may not be sufficient for C. jejuni since auxotrophic mutants unable to synthesize branched-chain and aromatic amino acids or Ser exhibit a colonization defect. We show that C. jejuni overcomes such substrate restriction through an active TCA cycle, gluconeogenesis, and nonoxidative PPP, which together facilitate its anabolic capacity and are crucial for its in vitro and in vivo growth. C. jejuni preferentially colonizes the mucus of the intestinal crypts [54–56], where it is spatially segregated from the luminal microbiota [86,87]. This spatial separation may allow C. jejuni to thrive despite its limited metabolic capacity. Indeed, while other enteropathogenic bacteria like Salmonella exhibit redundant catabolic pathways that allow the exploitation of multiple nutrients , our analyses clearly showed that the metabolic network of C. jejuni lacks comparable redundancy and harbors various bottlenecks, as it depends on the gluconeogenic activity of the EMP pathway and the nonoxidative PPP. These metabolic bottlenecks may allow the development of novel strategies to prevent colonization and novel anti-infective drugs.
Materials and methods
Bacterial strains, mutant library, and culture conditions
The complete list of strains and plasmids used in this study is shown in S9 Table. The highly saturated Himar 1 Mariner transposon mutant library has been previously described . The C. jejuni 81–176 strains were grown on brucella broth agar or on blood agar plates (Trypticase soy agar supplemented with 5% sheep blood) at 37°C in an incubator equilibrated to a 10% CO2 atmosphere. The C. jejuni transformants were selected on plates supplemented with 50 μg/ml kanamycin, 7.5 μg/ml chloramphenicol, and 10 μg/ml erythromycin as indicated. For liquid cultures, C. jejuni strains were grown in brain heart infusion (BHI) medium with no antibiotics added in most cases except for the growth of the mutant library or defined C. jejuni mutant strains (see below). All C. jejuni strains were stored at −80°C in BHI broth containing 30% glycerol.
Screening of the transposon mutant library for their ability to grow in vitro
For growth in rich-medium experiments, approximately 108 CFUs of the C. jejuni transposon mutant library were plated on blood agar in 15-cm petri dishes, and the bacterial cells were collected after 48 hours. Six replicates of this growth condition were processed as described below. For growth in liquid defined minimal medium, 108 CFUs of the C. jejuni transposon mutant library were added to 4 ml of DMEM (GIBCO; catalogue number 11965) supplemented with 20 mM Asp, Gln, or Ser. The culture tubes were placed on a rotating wheel in 10% CO2 atmosphere for 48 hours, and the bacterial cells were collected by centrifugation. Three replicates for each of these growth conditions were processed as described below. DNA extraction and sequencing were carried out as previously described . The sequencing data were analyzed using the INSeq_pipeline_v2 package . For this analysis, the sequencing data of each sample were normalized to total counts per million (i.e., the number of transposon insertions at each site was multiplied by 106 and then divided by the total number of insertions in the sample) [90,91]. This normalization step enabled comparison of the relative abundance change of each insertion mutant in the mutant library across different samples. Alternatively, the data were normalized using the median values of the number of reads. In this case, the median read number for all transposon insertions was calculated in each sample and normalized to a median read number of 50. To identify significant fitness genes under different growth conditions, a Z-test was applied to all gene mutants whose log-transformed output:input ratios were significantly different from the overall distribution across all biological replicates . Consequently, only genes with a q-value of <0.05 from the Z-test were considered significantly altered from the input. All deep-sequencing data filtering, normalization, mapping, and statistical analysis were conducted in Perl and R.
Screening of the transposon mutant library for their ability to colonize the mouse intestine
All animal experiments were conducted according to protocols approved by the Yale University Institutional Animal Care and Use Committee. Six- to eight-week-old C57BL/6 mice were treated with antibiotics in drinking water for 4 weeks to eradicate their commensal gut flora and allow robust C. jejuni colonization as previously described . Antibiotics were added to drinking water at the following concentration: ampicillin, 1 mg/ml; neomycin sulfate, 1 mg/ml; ciprofloxacin 200 μg/ml; metronidazole, 1 mg/ml; and vancomycin, 500 μg/ml. Antibiotics were removed from drinking water 2 days prior to the oral administration through stomach gavage of 100 μl of sodium bicarbonate (to neutralize the stomach pH) followed by the oral administration of 109 CFUs of C. jejuni in 100 μl of PBS. Mutants were reisolated 4 and 21 days after the mice were inoculated with the transposon insertion pools. Analysis of the mutants recovered 21 days post infection revealed a marked increase in insertions within the pVir and pTet plasmids with a drastic reduction in the representation of the mutant pool. Although the reasons for the “blooming” of these mutants late in infection are unclear, their emergence precluded the use of this time point to analyze C. jejuni colonization determinants. Consequently, the mutant library screen was performed by killing the mice and homogenizing their ceca with a tissue homogenized 4 days after infection. Bacteria were recovered from the cecum homogenates by plating on 15-cm blood agar petri dish plates (3 plates per cecum sample) containing Campylobacter selective supplements (Karmali, Oxoid SR0167). Colonies were scraped off the plates, and the genomic DNA was isolated as previously described . The INseq DNA sample preparation, sequencing, and data analysis were carried out as described above.
C. jejuni mutant strain construction
C. jejuni 81–176 knockout mutant strains were constructed as previously described . Briefly, flanking regions of the selected open reading frames (ORFs) were amplified with specific primers, linked to either side of a kanamycin (aphA3), an erythromycin (erm), or a chloramphenicol (cat) resistance cassette, and cloned into the pBluescript II SK using the Gibson assembly protocol . The resulting plasmids were used to move the mutated alleles into the chromosome of C. jejuni 81–176 by natural transformation and allelic recombination. Complementation of the mutant strains of C. jejuni was achieved by introducing a wild-type copy of the gene at the hsdM locus as previously described . The plasmids used to generate the mutants are listed in S9 Table.
In vivo colonization competition assays
Six- to eight-week-old C57BL/6 mice were infected by oral gavage with 109 CFUs of the different C. jejuni mutants mixed with an equal number of the wild-type parent strain. To enumerate bacterial loads in the cecum, mice were killed 4 days after infection, ceca were homogenized in 3 ml PBS containing 0.05% sodium deoxycholate, and the dilutions were plated on blood agar plates with Campylobacter selective supplements with and without the selection antibiotics to determine the CFUs of the wild-type and mutant strains.
Cultivation of C. jejuni for isotopologue analysis was performed as described in S1 Text. Sample preparation for isotopologue analysis by GC/MS was performed as previously described . During sample preparation, the acidic hydrolysis of cellular proteins did not allow the determination of Asn, Cys, Gln, Met, and Trp: Cys and Met are destroyed during the hydrolysis procedure, whereas Asn and Gln are converted to Asp and Glu, respectively. Consequently, the values for Asp and Glu correlate with the averages of Asn/Asp and Gln/Glu [95,96].
Amino acid uptake by C. jejuni
C. jejuni 81–176 was grown in 50 ml Hank’s Balanced Salt Solution supplemented with iron(II)ascorbate (Sigma), MEM Vitamin Solution (Invitrogen), and 1% Casamino acids (Roth) as a carbon source. The liquid cultures were incubated under reduced-oxygen atmosphere using Anaerocult C-Packs (Merck) at 37°C under shaking (150 rpm) conditions. The uptake of amino acids through C. jejuni 81–176 was investigated by analyzing the changes in the amount of the amino acids in the culture supernatants. Samples of 2 ml supernatant were taken at the indicated time points, the bacterial cells were removed by centrifugation (17,000 g, 5 min, 4°C), and an aliquot of the filtrated supernatant was used for GC/MS analysis. The 100 μl aliquot of the supernatant was diluted in 500 μl water, containing 4 μg of ribitol as an internal standard. The samples were mixed, dried under vacuum at room temperature, and stored at −20°C. Derivatization of the samples was done with 40 μl pyridine, containing methoxyamine hydrochloride (20 mg/ml) and 60 μl N-Methyl-N-trimethylsilyltrifluoro-acetamide (MSTFA). The GC/MS analysis was done on a Thermo GC Ultra coupled to a DSQII mass spectrometer equipped with an AS3000 autosampler (ThermoScientific, Dreieich, Germany) as described before , with the following exceptions: helium flow was set to 1.1 ml/min, and the temperature was increased to a final 325°C. The solvent delay time was 5.80 min. Data analysis was performed with Metabolite Detector (version 2.07; ), and quantification was done using 1 unique fragment ion for each metabolite. For statistical analysis, data were first normalized by dividing the peak area of every detected compound in each sample by the peak area of the respective internal standard ribitol. Afterwards, the mean and the standard deviation were calculated from 3 biological samples with 3 technical replicates each.
Defined drop-out amino acid medium (DAAM) for C. jejuni liquid cultures
To investigate the growth properties of amino-acid auxotrophic C. jejuni 81–176 mutants, the different strains were cultivated in a defined DAAM based on Hank’s Balanced Salt Solution with each amino acid present in 2 mM concentration supplemented with vitamin mix, 10 μM ferrous ascorbate, and 20 mM lactate as described before .
In vitro growth and motility plate assays
To compare the growth of the C. jejuni ktr and kdp mutants with the wild-type strain in the presence or absence of K+, strains were inoculated (starting OD600 of 0.02) into 4 ml of liquid defined rich medium (S10 Table) with or without the addition of 0.5 or 5 mM KCl. Cultures were incubated on a rotating wheel under 10% CO2 atmosphere, and the OD600 were measure at the indicated times after inoculation. All experiments were performed at least 3 times.
For the motility assay, the optical density of the bacterial cultures was adjusted to an OD600 of 0.3, and 10 μl was spotted onto soft agar (0.5%, wt/vol). The plates were incubated for 24 hours at 37°C, and the swarming diameters of the different strains were compared to the wild type and the nonmotile C. jejuni ΔmotA mutant strain.
S1 Fig. Labeling of polar metabolites in C. jejuni 81–176 upon cultivation with [3-13C1]Ser.
Shown are the 13C-incorporation (13C-excess) and the relative isotopologue distributions into polar metabolites isolated from the cytoplasm of C. jejuni after incubation with [3-13C1]Ser. Illustrated are the means ± SD of 6 measurements with the colored boxes indicating the relative isotopologue contributions [%] with 1, 2, 3, 4, 5, 6, 7, 8 and 9 13C-atoms corresponding to M+1, M+2, M+3, M+4, M+5, M+6, M+7, M+8 and M+9, respectively (see S11 Table).
S2 Fig. Amino acid uptake ability of C. jejuni 81–176.
(A) Scheme presenting the predicted amino acid uptake capacity of C. jejuni 81–176 according to the INSeq analysis. Viable mutants with transposon insertions in the indicated amino acid biosynthesis pathways have been identified in the screen suggesting the import of respective amino acids. No transposon insertions in the glycine biosynthesis genes glyA have been identified and the aminotransferase required for the generation of Ala from Pyr has not yet been reported. (B) Growth analysis of C. jejuni 81–176 wild-type strain and amino acid auxotrophic mutants in defined DAAM media in the presence or absence of the indicated amino acids. The maximal OD600 within 48 h of incubation are depicted and represent the means ± SD of three independent experiments (see S12 Table).
S3 Fig. Amino acid utilization by C. jejuni 81–176 determined by exometabolome analysis.
The uptake of amino acids by C. jejuni 81–176 was examined by measuring their concentrations in the culture supernatants within 24 h of cultivation relative to their original concentration prior to bacterial inoculation, which was considered to be 100%. Shown are the mean values ± SD of three independent experiments measured in triplicates (see S13 Table). Significant amino acid uptake were detectable for Asp, Glu, Pro, Ser, Cys, Met and Thr with * P < 0.05, ** P < 0.01 and *** P < 0.001 calculated by Student’s unpaired t-test.
S4 Fig. Colony forming units of commensal bacteria in mice feces before and after antibiotic treatment.
Shown is the intestinal bacterial load after antibiotic treatment of animals immediately prior to infection with C. jejuni. Collected feces samples from each mouse were dissolved and diluted serially with PBS buffer, then plated on blood agar in duplicates. One half of plates were incubated in 10% CO2 incubator as “aerobic condition”, the other half of plates were placed in anaerobic jar as “anaerobic condition”. CFU determination was carried out after 48 h incubation (see S14 Table).
S5 Fig. In vivo fitness of C. jejuni insertion mutants determined by INSeq analysis.
Relative abundance of C. jejuni insertion mutants in the inoculum and the mouse cecum samples after infection for 4 (A), 7 (B) and 21 (C) days. In (A) and (B), each point represents the average abundance of read numbers of a single gene obtained from 13 or 5 mice, respectively, and are normalized to per million reads. In (C), each point represents the abundance of read numbers of a single gene from a single mouse infection, which is normalized to per million reads. (D) Summary of number of insertion mutants recovered from mouse ceca at the indicated days after infection.
S6 Fig. Log2 (output/input) ratio distribution of all insertions during mouse colonization.
Histogram depicting the number of genes (y axis) that exhibited the indicated log2 [fold change (output/input)] change (x axis) in the numbers of transposon insertions recovered from infected mice relative to the number of transposon insertions in the original inoculum. Areas colored with red represent genes whose number of transposon insertions showed a significant decrease after mouse infection. For this analysis the data were normalized using the median values of the number of reads (see Materials and Methods; S4 Table).
S7 Fig. Contribution of a C. jejuni motility-associated gene cluster to mouse colonization.
(A)Blue and red bars indicate the normalized read number of each insertion site within the different ORFs in the input and output pool, respectively. Motility assays (B) and growth curves (see S12 Table) (C) for wild-type C. jejuni 81–176 and the ΔCJJ81176_0479, ΔCJJ81176_0480, or ΔCJJ81176_0481 mutants.
S8 Fig. Role of amino acid biosynthesis of C. jejuni 81–176 in mouse colonization.
Illustrated is the impact of amino acid biosynthesis pathways in C. jejuni mouse intestinal colonization as determined by INSeq analysis. Numbers indicate the log2 value of fold change (intestine/inoculum) in the number of insertions in the indicated genes and are derived from the raw data in S3 Table. Values below -6.2 indicate mutations led to a statistically significant colonization defect. *: denotes genes showing a limited number of insertions within the library and no insertions within the pooled of mutants recovered from the intestine. §: input pool of INSeq analyses lack mutants with transposon insertions within this gene.
S9 Fig. Amino acid composition of all predicted proteins encoded by C. jejuni 81–176.
The frequency of all amino acids in all predicted proteins are shown and branched-chain amino acids are highlighted in orange. Calculations were carried out using BacMap (http://wishart.biology.ualberta.ca/BacMap/cgi/getGraphs.cgi?accession=NC_008787&ref=index_2.html).
S10 Fig. Growth properties of serine-biosynthesis defective C. jejuni mutants.
Wild type C. jejuni 81–176 (WT) and the indicated isogenic mutant strains (serA: D-3-phosphoglycerate dehydrogenase; sdaA: L-serine ammonia-lyase/dehydratase) were grown in defined medium (DAAM) in the presence or absence of serine as indicated. Lactate or glutamate are provided as general energy/carbon source. Values represent the mean ± SD of the maximal optical density (OD600) reached after 48 h of growth in 3 independent experiments (see S12 Table).
S11 Fig. Role of methionine and S-adenosyl methionine (SAM) biosynthesis in C. jejuni 81–176 in vivo growth.
Illustrated is the impact of methionine and SAM biosynthesis in C. jejuni mouse intestinal colonization as determined by INSeq analysis. Numbers indicate the log2 value of fold change (intestine/inoculum) in the number of insertions in the indicated genes and are derived from the raw data in S3 Table. Values below -6.2 indicate mutations led to a statistically significant colonization defect. *: denotes genes showing a limited number of insertions within the library and no insertions within the pooled of mutants recovered from the intestine.
S12 Fig. 13C-incorporation and isotopologue profiles of protein-derived amino acids in C. jejuni 81–176 after incubation with [5-13C1]-Glu in DMEM medium.
Black columns on the left y axis represent percentage of 13C-excess (mol %) into the respective protein-derived amino acids. The colored columns on the right y axis depict the percentages of labeled isotopologues comprising up to six labeled 13C atoms (M+1 to M+6). Values are the means ± SD of 6 measurements (see S11 Table).
S13 Fig. Schematic overview of the 13C-flux into protein-derived amino acids after catabolism of [5-13C1]-Glu in C. jejuni 81–176.
The positions of the 13C-label of the amino acid isotopologues are indicated by the colored dots. Due to the stereoisomerism of the TCA-cycle intermediates succinate and fumarate, it is not possible to distinguish between the C1- or the C4-carbon atom 13C-label. Consequently, the possibilities of the 13C in OAA and its derived amino acids are indicated in red and orange, both colors displaying a 50% possibility that the carbon atom acquired the label. Green arrows depict the synthesis of the amino acids from their respective precursor molecules. The individual reactions of the multi-step amino acid biosynthesis pathways are not displayed.
S14 Fig. Role of the “acetate switch” in mouse colonization.
Six mice were inoculated with an equal number of wild-type C. jejuni 81–176 and the ΔackA isogenic mutant strain via oral gavage. Competitive indices (CI) were calculated as the ratio of the CFU of the ΔackA mutant over wild type recovered from the ceca of infected mice (see S14 Table).
S15 Fig. Impact of the non-oxidative pentose phosphate pathway (PPP) on the growth of C. jejuni 81–176.
Shown is the impact of the inactivation of genes encoding components of the PPP pathway in C. jejuni mouse intestinal colonization as determined by INSeq analyses. Numbers indicate the log2 value of fold change (intestine/inoculum) in the number of insertions in the indicated genes and are derived from the raw data in S3 Table. Values below -6.2 indicate mutations led to a statistically significant colonization defect. Genes with no insertions in the library are denoted in greeen. *: denotes genes showing a limited number of insertions within the library and no insertions within the pooled of mutants recovered from the intestine.
S16 Fig. Impact of the purine and pyrimidine biosynthesis pathways on the in vivo growth of C. jejuni 81–176.
Shown is the impact of the inactivation of genes encoding components of the purine and pyrimidine biosynthesis pathways in C. jejuni mouse intestinal colonization as determined by INSeq analyses. Numbers indicate the log2 value of fold change (intestine/inoculum) in the number of insertions in the indicated genes and are derived from the raw data in S3 Table. Values below -6.2 indicate mutations led to a statistically significant colonization defect. Red arrows denote that the number of insertions within the gene that catalyze the indicated reaction was significantly reduced within the pooled of mutants recovered from the mouse intestine relative to the inoculum. Green arrows indicate that the genes encoding the enzymes that catalyze the corresponding reactions do not have insertional mutants in the library. *: denotes genes showing a limited number of insertions within the library and no insertions within the pooled of mutants recovered from the intestine.
S17 Fig. Core metabolic reactions of C. jejuni 81–176 that generate carbon dioxide.
Selected metabolic reactions in C. jejuni that release carbon dioxide (CO2). Numbers indicate the log2 value of fold change (intestine/inoculum) in the number of insertions in the indicated genes and are derived from the raw data in S3 Table. Values below -6.2 indicate mutations led to a statistically significant colonization defect. Red arrows denote that the number of insertions within the gene that catalyze the indicated reaction was significantly reduced within the pooled of mutants recovered from the mouse intestine relative to the inoculum. In green arrows indicate that the genes encoding the enzyme that catalyzes the corresponding reaction are noted genes with no insertions in our mutant library. *: denotes genes showing a limited number of insertions within the library and no insertions within the pooled of mutants recovered from the intestine.
S1 Table. INSeq raw data for each C. jejuni gene after growth under different in-vitro growth condition.
S2 Table. List of genes that show similar mutant phenotype according to the Venn diagram depicted in Fig 1B and 1C.
S3 Table. INSeq raw data for each gene in mouse colonization experiments.
S4 Table. INSeq raw data for each gene in mouse colonization experiments, which were normalized by median nomarlization method.
S5 Table. Analysis of potential polar effects of transposon insertions.
S6 Table. Growth-promoting substrates utilized by Campylobacter jejuni during colonization of gastrointestinal tract.
S7 Table. Summary of INSeq data for Tlp and chemotaxis proteins in C. jejuni 81–176.
S8 Table. Summary of potassium channel and transporters in Epsilon-proteobacteria.
S9 Table. Strains and plasmids used in this study.
S10 Table. Composition of a modified defined DMEM medium for Campylobacter jejuni 81–176 used in the indicated studies.
We thank members of the Galán laboratory for critical review of this manuscript and Kerstin Schmidt-Hohagen as well as Dietmar Schomburg (Technische Universität Braunschweig) for experimental support.
- 1. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, et al. (1999) Food-related illness and death in the United States. Emerg Infect Dis 5: 607–625. pmid:10511517
- 2. Kaakoush N, Castaño-Rodríguez N, Mitchell H, Man S (2015) Global epidemiology of Campylobacter infection. Clin Microbiol Rev 28: 687–719. pmid:26062576
- 3. Hale C, Scallan E, Cronquist A, Dunn J, Smith K, et al. (2012) Estimates of enteric illness attributable to contact with animals and their environments in the United States. Clin Infect Dis 54: S472–S479. pmid:22572672
- 4. Horrocks SM, Anderson RC, Nisbet DJ, Ricke SC (2009) Incidence and ecology of Campylobacter jejuni and coli in animals. Anaerobe 15: 18–25. pmid:18849005
- 5. van Doorn P, Ruts L, Jacobs B (2008) Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7: 939–950. pmid:18848313
- 6. Young K, Davis L, Dirita V (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5: 665–679. pmid:17703225
- 7. Gilbreath JJ, Cody WL, Merrell DS, Hendrixson DR (2011) Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter. Microbiol Mol Biol Rev 75: 84–132. pmid:21372321
- 8. Epps S, Harvey R, Hume M, Phillips T, Anderson R, et al. (2013) Foodborne Campylobacter: infections, metabolism, pathogenesis and reservoirs. Int J Environ Res Public Health 10: 6292–6304. pmid:24287853
- 9. Guerry P (2007) Campylobacter flagella: not just for motility. Trends Microbiol 15: 456–461. pmid:17920274
- 10. Karlyshev AV, Ketley JM, Wren BW (2005) The Campylobacter jejuni glycome. FEMS Microbiol Rev 29: 377–390. pmid:15808749
- 11. Hofreuter D (2014) Defining the metabolic requirements for the growth and colonization capacity of Campylobacter jejuni. Front Cell Infect Microbiol 4: 137. pmid:25325018
- 12. Young KT, Davis LM, Dirita VJ (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5: 665–679. pmid:17703225
- 13. Brown SA, Palmer KL, Whiteley M (2008) Revisiting the host as a growth medium. Nat Rev Microbiol 6: 657–666. pmid:18679171
- 14. Abu Kwaik Y, Bumann D (2013) Microbial quest for food in vivo: 'nutritional virulence' as an emerging paradigm. Cell Microbiol 15: 882–890. pmid:23490329
- 15. Bäumler AJ, Sperandio V (2016) Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535: 85–93. pmid:27383983
- 16. Rohmer L, Hocquet D, Miller SI (2011) Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol 19: 341–348. pmid:21600774
- 17. Zhang YJ, Rubin EJ (2013) Feast or famine: the host-pathogen battle over amino acids. Cell Microbiol 15: 1079–1087. pmid:23521858
- 18. Grant AJ, Coward C, Jones MA, Woodall CA, Barrow PA, et al. (2005) Signature-tagged transposon mutagenesis studies demonstrate the dynamic nature of cecal colonization of 2-week-old chickens by Campylobacter jejuni. Appl Environ Microbiol 71: 8031–8041. pmid:16332783
- 19. Hendrixson DR, DiRita VJ (2004) Identification of Campylobacter jejuni genes involved in commensal colonization of the chick gastrointestinal tract. Mol Microbiol 52: 471–484. pmid:15066034
- 20. Hermans D, Van Deun K, Martel A, Van Immerseel F, Messens W, et al. (2011) Colonization factors of Campylobacter jejuni in the chicken gut. Vet Res 42: 82. https://doi.org/10.1186/1297-9716-42-82 pmid:21714866
- 21. Goodman AL, Wu M, Gordon JI (2011) Identifying microbial fitness determinants by insertion sequencing using genome-wide transposon mutant libraries. Nat Protoc 6: 1969–1980. pmid:22094732
- 22. van Opijnen T, Bodi K, Camilli A (2009) Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods 6: 767–772. pmid:19767758
- 23. Gawronski J, Wong S, Giannoukos G, Ward D, Akerley B (2009) Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A 106: 16422–16427. pmid:19805314
- 24. Young VB, Schauer DB, Fox AJ (2000) Animal models of Campylobacter infection. In: Nachamkin I, Blaser MJ, editors. Campylobacter. Second ed. Washington, DC: ASM Press. pp. 287–301.
- 25. Johnson J, Livny J, Dirita V (2014) High-throughput sequencing of Campylobacter jejuni insertion mutant libraries reveals mapA as a fitness factor for chicken colonization. J Bacteriol 196: 1958–1967. pmid:24633877
- 26. Bereswill S, Fischer A, Plickert R, Haag L, Otto B, et al. (2011) Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS ONE 6: e20953. pmid:21698299
- 27. Gao B, Lara-Tejero M, Lefebre M, Goodman A, Galan J (2014) Novel Components of the Flagellar System in Epsilon Proteobacteria. MBio 5: e01349–01314. pmid:24961693
- 28. Kelly DJ (2001) The physiology and metabolism of Campylobacter jejuni and Helicobacter pylori. Symp Ser Soc Appl Microbiol: 16S–24S. pmid:11422557
- 29. Hofreuter D, Novik V, Galan JE (2008) Metabolic diversity in Campylobacter jejuni enhances specific tissue colonization. Cell Host Microbe 4: 425–433. pmid:18996343
- 30. Leach S, Harvey P, Wali R (1997) Changes with growth rate in the membrane lipid composition of and amino acid utilization by continuous cultures of Campylobacter jejuni. J Appl Microbiol 82: 631–640. pmid:9172406
- 31. Stahl M, Butcher J, Stintzi A (2012) Nutrient acquisition and metabolism by Campylobacter jejuni. Front Cell Infect Microbiol 2: 5.
- 32. Velayudhan J, Jones MA, Barrow PA, Kelly DJ (2004) L-serine catabolism via an oxygen-labile L-serine dehydratase is essential for colonization of the avian gut by Campylobacter jejuni. Infect Immun 72: 260–268. pmid:14688104
- 33. Ribardo DA, Hendrixson DR (2011) Analysis of the LIV system of Campylobacter jejuni reveals alternative roles for LivJ and LivK in commensalism beyond branched-chain amino acid transport. J Bacteriol 193: 6233–6243. pmid:21949065
- 34. Akashi H, Gojobori T (2002) Metabolic efficiency and amino acid composition in the proteomes of Escherichia coli and Bacillus subtilis. Proc Natl Acad Sci U S A 99: 3695–3700. pmid:11904428
- 35. Liu X, Gao B, Novik V, Galan JE (2012) Quantitative Proteomics of Intracellular Campylobacter jejuni Reveals Metabolic Reprogramming. PLoS Pathog 8: e1002562. pmid:22412372
- 36. Sheppard SK, Didelot X, Meric G, Torralbo A, Jolley KA, et al. (2013) Genome-wide association study identifies vitamin B5 biosynthesis as a host specificity factor in Campylobacter. Proc Natl Acad Sci U S A 110: 11923–11927. pmid:23818615
- 37. Crimmins G, Mohammadi S, Green E, Bergman M, Isberg R, et al. (2012) Identification of MrtAB, an ABC Transporter Specifically Required for Yersinia pseudotuberculosis to Colonize the Mesenteric Lymph Nodes. PLoS Pathog 8: e1002828. pmid:22876175
- 38. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, et al. (2001) A phase-variable capsule is involved in virulence of Campylobacter jejuni 81–176. Mol Microbiol 40: 769–777. pmid:11359581
- 39. Davis LM, Kakuda T, DiRita VJ (2009) A Campylobacter jejuni znuA orthologue is essential for growth in low-zinc environments and chick colonization. J Bacteriol 191: 1631–1640. pmid:19103921
- 40. Naito M, Frirdich E, Fields J, Pryjma M, Li JA, et al. (2010) Effects of sequential Campylobacter jejuni 81–176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis. J Bacteriol 192: 2182–2192. pmid:20139192
- 41. Novik V, Hofreuter D, Galan JE (2009) Characterization of a Campylobacter jejuni VirK protein homolog as a novel virulence determinant. Infect Immun 77: 5428–5436. pmid:19797067
- 42. Szymanski CM, Burr DH, Guerry P (2002) Campylobacter protein glycosylation affects host cell interactions. Infect Immun 70: 2242–2244. pmid:11895996
- 43. Lertsethtakarn P, Ottemann KM, Hendrixson DR (2011) Motility and chemotaxis in Campylobacter and Helicobacter. Annu Rev Microbiol 65: 389–410. pmid:21939377
- 44. Hugdahl MB, Beery JT, Doyle MP (1988) Chemotactic behavior of Campylobacter jejuni. Infect Immun 56: 1560–1566. pmid:3372020
- 45. Guccione E, Leon-Kempis M, Pearson B, Hitchin E, Mulholland F, et al. (2008) Amino acid-dependent growth of Campylobacter jejuni: key roles for aspartase (AspA) under microaerobic and oxygen-limited conditions and identification of AspB (Cj0762), essential for growth on glutamate. Mol Microbiol 69: 77–93. pmid:18433445
- 46. Novik V, Hofreuter D, Galán J (2010) Identification of Campylobacter jejuni genes involved in its interaction with epithelial cells. Infect Immun 78: 3540–3553. pmid:20515930
- 47. Hartley-Tassell LE, Shewell LK, Day CJ, Wilson JC, Sandhu R, et al. (2010) Identification and characterization of the aspartate chemosensory receptor of Campylobacter jejuni. Mol Microbiol 75: 710–730. pmid:20025667
- 48. Rahman H, King RM, Shewell LK, Semchenko EA, Hartley-Tassell LE, et al. (2014) Characterisation of a multi-ligand binding chemoreceptor CcmL (Tlp3) of Campylobacter jejuni. PLoS Pathog 10: e1003822. pmid:24391495
- 49. Day CJ, Hartley-Tassell LE, Shewell LK, King RM, Tram G, et al. (2012) Variation of chemosensory receptor content of Campylobacter jejuni strains and modulation of receptor gene expression under different in vivo and in vitro growth conditions. BMC Microbiol 12: 128. pmid:22747654
- 50. Beeby M, Ribardo DA, Brennan CA, Ruby EG, Jensen GJ, et al. (2016) Diverse high-torque bacterial flagellar motors assemble wider stator rings using a conserved protein scaffold. Proc Natl Acad Sci U S A 113: E1917–1926. pmid:26976588
- 51. Hendrixson DR (2006) A phase-variable mechanism controlling the Campylobacter jejuni FlgR response regulator influences commensalism. Mol Microbiol 61: 1646–1659. pmid:16899076
- 52. Hendrixson DR (2008) Restoration of flagellar biosynthesis by varied mutational events in Campylobacter jejuni. Mol Microbiol 70: 519–536. pmid:18761684
- 53. Mohawk KL, Poly F, Sahl JW, Rasko DA, Guerry P (2014) High frequency, spontaneous motA mutations in Campylobacter jejuni strain 81–176. PLoS ONE 9: e88043. pmid:24558375
- 54. Beery JT, Hugdahl MB, Doyle MP (1988) Colonization of gastrointestinal tracts of chicks by Campylobacter jejuni. Appl Environ Microbiol 54: 2365–2370. pmid:3060015
- 55. Lee A, O'Rourke JL, Barrington PJ, Trust TJ (1986) Mucus colonization as a determinant of pathogenicity in intestinal infection by Campylobacter jejuni: a mouse cecal model. Infect Immun 51: 536–546. pmid:2935499
- 56. Stahl M, Vallance BA (2015) Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection. Gut Microbes 6: 143–148. pmid:25831043
- 57. Leon-Kempis Mdel R, Guccione E, Mulholland F, Williamson MP, Kelly DJ (2006) The Campylobacter jejuni PEB1a adhesin is an aspartate/glutamate-binding protein of an ABC transporter essential for microaerobic growth on dicarboxylic amino acids. Mol Microbiol 60: 1262–1275. pmid:16689801
- 58. Lin AE, Krastel K, Hobb RI, Thompson SA, Cvitkovitch DG, et al. (2009) Atypical roles for Campylobacter jejuni amino acid ATP binding cassette transporter components PaqP and PaqQ in bacterial stress tolerance and pathogen-host cell dynamics. Infect Immun 77: 4912–4924. pmid:19703978
- 59. Hofreuter D, Mohr J, Wensel O, Rademacher S, Schreiber K, et al. (2012) Contribution of amino acid catabolism to the tissue specific persistence of Campylobacter jejuni in a murine colonization model. PLoS ONE 7: e50699. pmid:23226358
- 60. Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, et al. (2013) Re-print of "Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host". Pharmacol Res 69: 114–126. pmid:23318949
- 61. Vorwerk H, Mohr J, Huber C, Wensel O, Schmidt-Hohagen K, et al. (2014) Utilization of host-derived cysteine-containing peptides overcomes the restricted sulfur metabolism of Campylobacter jejuni. Mol Microbiol 93: 1224–1245. pmid:25074326
- 62. Parsons CM, Potter LM, Brown RD Jr. (1983) Effects of dietary carbohydrate and of intestinal microflora on excretion of endogenous amino acids by poultry. Poult Sci 62: 483–489. pmid:6302653
- 63. Parveen N, Cornell KA (2011) Methylthioadenosine/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism. Mol Microbiol 79: 7–20. pmid:21166890
- 64. Hoffman PS, Sisson G, Croxen MA, Welch K, Harman WD, et al. (2007) Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Agents Chemother 51: 868–876. pmid:17158936
- 65. Wright J, Grant A, Hurd D, Harrison M, Guccione E, et al. (2009) Metabolite and transcriptome analysis of Campylobacter jejuni in vitro growth reveals a stationary-phase physiological switch. Microbiology 155: 80–94. pmid:19118349
- 66. Boll J, Hendrixson D (2011) A specificity determinant for phosphorylation in a response regulator prevents in vivo cross-talk and modification by acetyl phosphate. Proc Natl Acad Sci U S A 108: 20160–20165. pmid:22128335
- 67. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, et al. (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665–668. pmid:10688204
- 68. Velayudhan J, Kelly DJ (2002) Analysis of gluconeogenic and anaplerotic enzymes in Campylobacter jejuni: an essential role for phosphoenolpyruvate carboxykinase. Microbiology 148: 685–694. pmid:11882702
- 69. Gall LS (1968) The role of intestinal flora in gas formation. Ann N Y Acad Sci 150: 27–30. pmid:4868089
- 70. Al-Haideri H, White MA, Kelly DJ (2016) Major contribution of the type II beta carbonic anhydrase CanB (Cj0237) to the capnophilic growth phenotype of Campylobacter jejuni. Environ Microbiol 18: 721–735. pmid:26470757
- 71. Smith KS, Ferry JG (2000) Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 24: 335–366. pmid:10978542
- 72. Ma Z, Jacobsen FE, Giedroc DP (2009) Coordination chemistry of bacterial metal transport and sensing. Chem Rev 109: 4644–4681. pmid:19788177
- 73. Waldron KJ, Robinson NJ (2009) How do bacterial cells ensure that metalloproteins get the correct metal? Nat Rev Microbiol 7: 25–35. pmid:19079350
- 74. Hood MI, Skaar EP (2012) Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol 10: 525–537. pmid:22796883
- 75. Taveirne ME, Sikes ML, Olson JW (2009) Molybdenum and tungsten in Campylobacter jejuni: their physiological role and identification of separate transporters regulated by a single ModE-like protein. Mol Microbiol 74: 758–771. pmid:19919002
- 76. Hall SJ, Hitchcock A, Butler CS, Kelly DJ (2008) A Multicopper oxidase (Cj1516) and a CopA homologue (Cj1161) are major components of the copper homeostasis system of Campylobacter jejuni. J Bacteriol 190: 8075–8085. pmid:18931123
- 77. Padan E, Venturi M, Gerchman Y, Dover N (2001) Na(+)/H(+) antiporters. Biochim Biophys Acta 1505: 144–157. pmid:11248196
- 78. Epstein W (2003) The roles and regulation of potassium in bacteria. Prog Nucleic Acid Res Mol Biol 75: 293–320. pmid:14604015
- 79. Freeman ZN, Dorus S, Waterfield NR (2013) The KdpD/KdpE two-component system: integrating K(+) homeostasis and virulence. PLoS Pathog 9: e1003201. pmid:23555240
- 80. Staib L, Fuchs TM (2014) From food to cell: nutrient exploitation strategies of enteropathogens. Microbiology 160: 1020–1039. pmid:24705229
- 81. Conway T, Cohen PS (2015) Commensal and Pathogenic Escherichia coli Metabolism in the Gut. Microbiol Spectr 3.
- 82. Dandekar T, Astrid F, Jasmin P, Hensel M (2012) Salmonella enterica: a surprisingly well-adapted intracellular lifestyle. Front Microbiol 3: 164. pmid:22563326
- 83. Alteri C, Mobley H (2012) Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol 15: 3–9. pmid:22204808
- 84. Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ (1988) Experimental Campylobacter jejuni infection in humans. J Infect Dis 157: 472–479. pmid:3343522
- 85. Robinson DA (1981) Infective dose of Campylobacter jejuni in milk. Br Med J (Clin Res Ed) 282: 1584.
- 86. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, et al. (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 105: 15064–15069. pmid:18806221
- 87. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, et al. (2011) The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334: 255–258. pmid:21998396
- 88. Steeb B, Claudi B, Burton NA, Tienz P, Schmidt A, et al. (2013) Parallel exploitation of diverse host nutrients enhances Salmonella virulence. PLoS Pathog 9: e1003301. pmid:23633950
- 89. Goodman A, McNulty N, Zhao Y, Leip D, Mitra R, et al. (2009) Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6: 279–289. pmid:19748469
- 90. Brooks J, Gyllborg M, Cronin D, Quillin S, Mallama C, et al. (2014) Global discovery of colonization determinants in the squid symbiont Vibrio fischeri. Proc Natl Acad Sci USA 111: 17284–17289 pmid:25404340
- 91. Wu M, McNulty N, Rodionov D, Khoroshkin M, Griffin N, et al. (2015) Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides. Science 350: aac5992. pmid:26430127
- 92. Gibson D, Young L, Chuang R, Venter J, Hutchison Cr, et al. (2009) Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6: 343–345 pmid:19363495
- 93. Watson RO, Novik V, Hofreuter D, Lara-Tejero M, Galan JE (2007) A MyD88-deficient mouse model reveals a role for Nramp1 in Campylobacter jejuni infection. Infect Immun 75: 1994–2003. pmid:17194808
- 94. Vorwerk H, Huber C, Mohr J, Bunk B, Bhuju S, et al. (2015) A transferable plasticity region in Campylobacter coli allows isolates of an otherwise non-glycolytic food-borne pathogen to catabolize glucose. Mol Microbiol 98: 809–830. pmid:26259566
- 95. Eisenreich W, Slaghuis J, Laupitz R, Bussemer J, Stritzker J, et al. (2006) 13C isotopologue perturbation studies of Listeria monocytogenes carbon metabolism and its modulation by the virulence regulator PrfA. Proc Natl Acad Sci U S A 103: 2040–2045. pmid:16461909
- 96. Eylert E, Schar J, Mertins S, Stoll R, Bacher A, et al. (2008) Carbon metabolism of Listeria monocytogenes growing inside macrophages. Mol Microbiol 69: 1008–1017. pmid:18627458
- 97. Abu Dawud R, Schreiber K, Schomburg D, Adjaye J (2012) Human embryonic stem cells and embryonal carcinoma cells have overlapping and distinct metabolic signatures. PLoS ONE 7: e39896. pmid:22768158
- 98. Hiller K, Hangebrauk J, Jager C, Spura J, Schreiber K, et al. (2009) MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Anal Chem 81: 3429–3439. pmid:19358599